Eptacog beta

N/A

Report date: 2022/07/26 15:12:05

Base Information

Drug NameEptacog beta
Drug Alias NameTransgenically derived recombinant human Factor VIIaCOAGULATION FACTOR VIIA RECOMBINANTCoagulation factor VIIa (recombinant)-jncwSevenfactLR-769 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4] 
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsThrombastheniaHemophilia BHemophilia A
Global Approved IndicationsHemophilia BHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/04/01
Country/TerritoryCzechiaBulgariaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies SasRevo Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLfb Biotechnologies SasEmory UniversityLaboratoire Francais Du Fractionnement Et Des Biotechnologies
Inactive CompaniesRevo Biologics IncLaboratoire Français De Fractionnement Et De Biotechnologies
Active IndicationsThrombastheniaHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD08
Related LinksN/A